And while everyone’s working through the details, look to DUPIXENT MyWay for additional support. You can connect with DUPIXENT MyWay Nurse Educators by phone to receive supplemental injection training, help scheduling deliveries and prescription refills, or help navigating financial support options, such as copay assistance.

DUPIXENT MyWay® is a patient support program that may help eligible patients start and stay on track with DUPIXENT® (dupilumab) by providing tools, resources, and education throughout their treatment journey. DUPIXENT® is a prescription medicine FDA-approved to treat six conditions. Serious side effects can occur. Please see Important Safety Information and Prescribing Information and ...

DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 6 indications. The mechanism of dupilumab action has not been definitively established. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.

2 days ago · Dupixent may be used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupixent is given as a subcutaneous injection every 1 to 4 weeks. People can be taught how to self-administer it.

Oct 3, 2024 · Dupixent is the first treatment (and currently the only) treatment approved to treat Prurigo Nodularis in adults, a chronic, debilitating skin disease that has a significant impact on a person's quality of life. Dupixent does not contain steroids and is not an antibiotic. Dupixent is administered by subcutaneous injection (under the skin).

A caregiver or patient 12 years of age and older may inject DUPIXENT using the pre-filled syringe or pre-filled pen. In pediatric patients 12 to 17 years of age, administer DUPIXENT under the supervision of an adult. In pediatric patients 6 months to less than 12 years of age, administer DUPIXENT by a caregiver. Administration Instructions

Jan 13, 2025 · Dupilumab (brand name Dupixent) may be used to treat eczema (atopic dermatitis [AD]), eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupilumab is self-administered by subcutaneous (under the skin) injection every 1 …

For more information about DUPIXENT, go to www.DUPIXENT.com or call 1-844-DUPIXENT (1-844-387-4936). This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: September 2024

Oct 1, 2024 · Dupixent should be kept in its original carton to protect it from light. It must be stored in a refrigerator. Keep it between 36 to 46 F (2 to 8 C). You can store it at room temperature up to 77 F ...

Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13 receptor signalling (IL-4R, IL-13R), used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis. [6] [7] [8] [4] It is also used for the treatment of eosinophilic esophagitis, [9] prurigo nodularis [10] and COPD.